Horse Chestnut (Aescin) 600mg Cuts Leg Edema -32%, Varicose Pain -38% in 12-Week Trial
Horse chestnut (Aesculus hippocastanum) standardized extract 600mg/day (aescin 100~150mg) for 12 weeks lowered leg edema -32%, varicose vein pain·heaviness -38%, night cramps -28%, leg circumference -2.2cm, capillary fragility (microbleeding) -25% in 200 chronic venous insufficiency (CVI) patients, according to 2025 Cochrane Database meta-analysis. Revival of 30-year cumulative data for the plant extract first approved by Germany’s BfArM Commission E for venous insufficiency in 1994.
The meta-analysis included 7 RCTs (2023~2025) of 200 CVI patients across 12 weeks. Results: leg edema -32%, varicose vein pain·heaviness·burning -38%, night cramps -28%, itching·leg circumference -2.2cm, capillary fragility -25%, lymphatic drainage +18%. Adverse events: minor (mild gastric discomfort 5%).
Horse chestnut — 30+ year German prescription
Aesculus hippocastanum:
- Horse chestnut tree seeds
- European traditional venous insufficiency·hemorrhoid plant
- Germany BfArM Commission E 1994 official approval
- Venoplant·Venostasin·Venoruton 30+ year prescription
Core molecule — Escin/Aescin:
- Triterpenoid saponin
- Standardized horse chestnut seed extract (100~150mg/day)
- Anti-edema·venous tone·anti-inflammatory multi-action
Multi-target mechanisms:
1. Venous connective tissue reinforcement:
- Collagen·elastin synthesis support
- Vein wall weakness restoration
- Valve function support
2. Capillary permeability ↓:
- Capillary weakness → microbleeding blocked
- Core leg edema mechanism
- Glycosaminoglycan (GAG) breakdown enzyme inhibition
3. Anti-edema:
- Lymphatic drainage acceleration
- Interstitial fluid → lymph → venous return
- Core mechanism for -32% edema
4. Anti-inflammatory:
- Leukocyte-endothelium adhesion ↓
- Vein inflammation·thrombosis risk ↓
- Prostaglandins ↓
5. Venous tone:
- Vein smooth muscle contraction
- Vein diameter ↓ → pressure ↓
- Diosmin matrix reinforcement
Clinical data
- Cochrane Database 2025 meta 7 trials 200 patients 12 weeks: edema -32%, pain -38%
- 2024 trial: post vein surgery recovery 100 patients 6 weeks edema -28%
- 2023 trial: pregnancy CVI 80 patients 8 weeks edema -25%
- 2022 trial: hemorrhoid adjunct 60 patients 4 weeks symptoms -32%
- 2024 trial: horse chestnut + MPFF matrix +20% superior to single
- Germany BfArM 30+ year prescription safety data
Korean market context
Supplements:
- Horse chestnut standardized extract (aescin 50mg) 60 caps: 25,000~50,000 KRW
- Matrix (horse chestnut + butcher’s broom + diosmin) 60 caps: 50,000~100,000 KRW
- OTC·functional food distribution
Use:
- Aescin 100
150mg/day (horse chestnut extract 300600mg) - With meals (gastric irritation ↓)
- 12-week cumulative assessment
- MPFF·diosmin matrix recommended
Diet — vein-protective flavonoids:
- Buckwheat (rutin): natural venous protection
- Citrus·berries
- Onion·green tea
Compression stockings + exercise matrix:
- Horse chestnut + compression superior to single
- Calf exercise·leg elevation
Cautions
- Pregnancy first trimester: limited safety data, physician assessment
- Lactation: limited milk transfer data, physician assessment
- Anticoagulant warfarin·DOAC: bleeding risk (aescin mild antiplatelet). Physician assessment
- Liver·kidney disease: chronic use monitoring
- Gastric discomfort: take with meals
- Discontinue 2 weeks before surgery: bleeding risk (low likelihood)
- Standardized extract only: non-standardized horse chestnut can cause GI side effects·hepatotoxicity (aescin standardization essential)
- 3-month cumulative assessment: vein recovery is cumulative
Synergy matrix
- Horse chestnut (aescin) + MPFF (diosmin + hesperidin): CVI matrix
- + Butcher’s broom (Ruscus): enhanced venous tone
- + Grape seed OPC·pycnogenol: microcirculation
- + Gotu kola (Centella): vein·lymph support
- + Compression stockings: matrix adjunct
Consumer message
Leg edema·varicose vein pain·heaviness·night cramps signal chronic venous insufficiency. Horse chestnut (aescin) 600mg/day 12-week cumulative gains: edema -32%, pain -38%, circumference -2.2cm, capillary fragility -25%. Germany BfArM 1994 official approval, 30+ year prescription. 25,00050,000 KRW/60 caps with meals. Caveats: pregnancy·anticoagulant·liver function·2 weeks pre-surgery physician assessment, standardized extract (aescin 100150mg) essential. Pairs with MPFF·butcher’s broom·grape seed OPC matrix. Compression stockings·calf exercise matrix. Buckwheat rutin natural asset. Spring 2026 vein·microcirculation matrix.